MT

Mickaël TERME

OP Ogd2 Pharma: 6 patents #1 of 8Top 15%
UN Universite De Nantes: 3 patents #24 of 365Top 7%
CN CNRS: 1 patents #3,857 of 11,908Top 35%
IL Institut De Cancerologie De L'Ouest: 1 patents #6 of 15Top 40%
NU Nantes Universite: 1 patents #9 of 41Top 25%
Overall (All Time): #809,320 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11697689 Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs Stephane Birkle, Julien FLEURENCE, Sébastien FARAJ, Jean-Marc Le Doussal, Denis Cochonneau +1 more 2023-07-11
11440968 Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2) Jean-Marc Le Doussal, Mylene Dorvillius, Brigitte Assouline 2022-09-13
10745489 Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer Stephane Birkle, Denis Cochonneau, Mylene Dorvillius, Jean-Marc Le Doussal 2020-08-18
10669328 Human IgG1 derived antibody with pro-apoptotic activity Mylene Dorvillius, Jean-Marc Le Doussal 2020-06-02
10611848 Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity Jean-Marc Le Doussal, Mylene Dorvillius 2020-04-07
10000575 Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer Stephane Birkle, Denis Cochonneau, Mylene Dorvillius, Jean-Marc Le Doussal 2018-06-19